http://www.nabriva.com
Nabriva Therapeutics plc Company Intro
Nabriva Therapeutics is a commercial-stage biopharmaceutical company engaged in the development of innovative anti-infective agents to treat serious infections.
Industry
Healthcare
Nabriva Therapeutics plc Headquaters
25-28 North Wall Quay
Dublin,1
Ireland
Nabriva Therapeutics plc Share price
17 May 2023 13:35 GMT
$1.6300
-0.04 (-2.4 %)
Nabriva Therapeutics plc Market cap
$5.442 M
WMC RANKING
2024
Nabriva Therapeutics plc # 226
BiotechnologyLatest Nabriva Therapeutics plc News
13 Feb 2024
Nabriva Therapeutics (NASDAQ:NBRV) Research Coverage Started at StockNews.com
Read Nabriva Therapeutics (NASDAQ:NBRV) Research Coverage Started at StockNews.com at Defense World.
13 Feb 2024
Nabriva Therapeutics (NASDAQ:NBRV) Research Coverage Started at StockNews.com
Read Nabriva Therapeutics (NASDAQ:NBRV) Research Coverage Started at StockNews.com at Defense World.
13 Feb 2024
Nabriva Therapeutics (NASDAQ:NBRV) Research Coverage Started at StockNews.com
Read Nabriva Therapeutics (NASDAQ:NBRV) Research Coverage Started at StockNews.com at Defense World.
WMC Market Score
WMC Market to Revenue Score
Nabriva Therapeutics plc Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Nabriva Therapeutics plc | USD | $4,695 | $63,261 | $-60,206 | $54M | 226 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $804,390B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $878,880B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ 0.00 | 3 |
| ALK-Abello A/S | USD | $3,556,000 | $1,893,000 | $66,000 | $189,400B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Nabriva Therapeutics plc Social Followers vs Top 4 Industry Competitors
Nabriva Therapeutics plc Post vs Top 4 Industry Competitors
Nabriva Therapeutics plc Digital Footprint By Size vs Top 4 Industry Competitors
Nabriva Therapeutics plc Digital Footprint By Change Rate vs Top 4 Industry Competitors
Nabriva Therapeutics plc WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Nabriva Therapeutics plc | 0.05 | 0 | 0 | 0 | 0 | 0 | 0 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 70 | 0 | 0 | 39.85 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 100 | 0 | 0 | 51.56 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 80 | 0 | 0 | 100 |
| ALK-Abello A/S | 38.66 | 0 | 0 | 0 | 0 | 0 | 0 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
